Paper Search Console

Home Search Page About Contact

Journal Title

Title of Journal: Am J Hypertens

Search In Journal Title:

Abbravation: American Journal of Hypertension

Search In Journal Abbravation:

Publisher

Narnia

Search In Publisher:

DOI

10.1007/bf01894981

Search In DOI:

ISSN

0895-7061

Search In ISSN:
Search In Title Of Papers:

P473 Hypertension in subSaharan Africa

Authors: Kassim Seedat Yackoob
Publish Date: 2004/05/01
Volume: 17, Issue: S1, Pages: 205A-206A
PDF Link

Abstract

The available data from a few countries in subSaharan Africa SSA have highlighted the increasing importance of NonCommunicable Diseases NCD in this region and these countries have taken steps to develop relevant policies and programs to address this issue It is likely that Cardiovascular Diseases CVD are particularly poorly detected and treated in primary health care settings in SSA There is evidence that prevalence of CVD and hypertension is increasing rapidly in SSA Two recent surveys in SSA showed that control of BP 140/90 mmHg was less than 1 in Tanzania and 15 in Blacks in South Africa Countries in SSA should therefore be encouraged to establish country specific recommendations for the prevention and management of NCD as already recommended by the World Health Assembly and the World Health Organisation WHO Blacks in SSA develop complications of stroke heart failure renal failure and peripheral vascular disease from hypertension At present coronary heart disease is relatively uncommon probably because Blacks in SSA have lower cholesterol levels and higher highdensity lipoprotein cholesterol levels compared to the Caucasian population group in the Western world the Asian and Caucasian population in SSA and in African Americans Although there are good studies on the response and tolerability of antihypertensive drugs in SSA there are no longterm morbidity and mortality data availableRecommendations of the International Forum for Hypertension Control and Prevention in Africa IFHA have been documented It should be emphasised that while it is important to consider the science of medicine for the treatment of hypertension particular consideration should be given to costeffectiveness and affordability because many countries in SSA have severe resource restraints In some of them the health budget per capita does not exceed US10 per year and this is insufficient to address the needs posed by the double burden of NCD and infectious diseases including AIDS

Keywords:

References

.
Search In Abstract Of Papers:
Other Papers In This Journal:
  1. Effect of Sodium on Blood Pressure, Cardiac Hypertrophy, and Angiotensin Receptor Expression in Rats
  2. P-470: Cardiovascular risk factors in the elderly. accuracy of attention in primary care
  3. I37AN EXAMPLE OF RESEARCH IN HYPERTENSION IN LATIN AMERICA.
  4. P-132: Chronic cocaine abuse as a cause of left ventricular hypertrophy?
  5. P-405: Prevalence of asymptomatic coronary artery disease in men with vasculogenic erectile dysfunction: A prospective angiographic study
  6. P-554: Pulse pressure as a predictor factor for survival in patients with acute ishaemic stroke
  7. P-322: Impact of ambulatory pulse pressure and office pulse pressure on left ventricular hypertrophy in patients with essential hypertension
  8. G19Superiority of 3d VS 2d echocardiography for measurement of left ventricular mass: an in vivo canine anatomic validation.
  9. Role of Sex Steroids in Modulating Tumor Necrosis Factor Alpha-Induced Changes in Vascular Function and Blood Pressure
  10. P-269: Correlation between ascending aortic pressures and outcomes in patients with coronary artery disease
  11. P-403: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in patients with untreated essential hypertension
  12. P-403: Effect of short-term supplementation of potassium chloride and potassium citrate on blood pressure in patients with untreated essential hypertension
  13. Arterial compliance changes in diabetic normotensive patients after angiotensin-converting enzyme inhibition therapy
  14. G10Cardiovascular reactivity to mental stress task and serum lipid levels in young mildly hypertensive subjects?
  15. Evaluation of antihypertensive therapy with the combination of olmesartan medoxomil and hydrochlorothiazide
  16. G34Effects of a restricted sleep regimen on ambulatory blood pressure monitoring in normotensive subjects
  17. Effect of recombinant human erythropoietin therapy on ambulatory blood pressure in normotensive and in untreated borderline hypertensive hemodialysis patients
  18. Retinol-Binding Protein and Transferrin in UrineNew Markers of Renal Function in Essential Hypertension and White Coat Hypertension?
  19. P-397: Hypertension awareness, control and treatment in rural Mississippi: Morton Have-A-Heart Project
  20. Analysis of the 11β-Hydroxysteroid Dehydrogenase Type 2 Gene (HSD11B2) in Human Essential Hypertension
  21. P-481: Dopaminergic dilatation on cholinergic and electric induced contractions of rat isolated tracheal muscle
  22. P-298: Screening of adolescent hypertension, and evaluation of target organ damages. Results from the Debrecen hypertension study
  23. P-80: Diabetic masked hypertension: risk for stroke in Japanese
  24. Role of Aldosterone in Left Ventricular Hypertrophy in Hypertension
  25. An Extra-adrenal Abdominal Pheochromocytoma Causing Ectopic ACTH Syndrome
  26. P-190: The effect of accupril on circadian blood pressure patterns in hypertensive subjects with left ventricle hypertrophy
  27. P-238: Heart rate variability and ECG changes in 148 Danish patients after two years in the VALUE trial
  28. Re: Heusser et al: elevation of sympathetic activity by eprosartan in young male subjects
  29. G12Reproducibility of two mental stress tasks in subjects with borderline or mild hypertension.
  30. P-272: BP control and CV outcomes in hispanic and nonhispanic women with CAD and hypertension: Findings from invest
  31. P-340: Renal insufficiency is the most prevalent target-organ disease in primary care-attended essential hypertension
  32. P-156: Nitric oxide synthase inhibition mediated afferent and efferent arteriolar vasoconstriction involves L-type calcium channel activation
  33. ADVANCE in the Prevention of Cardiovascular Disease in Diabetic Patients
  34. P-280: Can a generalized transfer function describe the relationship between pressure waveforms in central and upper limb arteries?
  35. Reduction of Vessel Wall Inflammation in Hypertensive Patients: Is Physical Activity the Answer?
  36. P-241: Risk of cardiovascular events with amlodipine, lisinopril, or valsartan therapy in hypertension population
  37. P-357: Incidental renal artery stenosis in heart transplantation: Prevalence and clinical implications
  38. P-439: Hypertension and PLD2 regulation by D5 dopamine receptor
  39. Markers of Inflammation Are Inversely Related to Physical Activity and Fitness in Sedentary Men With Treated Hypertension
  40. P-517: Increased dietary sodium partially blunts the amelioration of insulin resistance induced by dietary potassium supplementation in a neuroendocrine model of visceral obesity
  41. Intrarenal Arterial Network Renin Content and Inhibition by EMD 58265
  42. P-692: 24-hr ambulatory mean blood pressure vs. pulse pressure as a predictor of silent cerebral infarcts in older Japanese hypertensives
  43. Interactions Between Melatonin and Estrogen in the Regulation of Blood Pressure in Women
  44. P-258: Prevalence, awareness, treatment and control of hypertension in Turkey (patent)
  45. B14The Effect Of Calcium And Vitamin D Supplements On Blood Pressure And Calcium Metabolism In Elderly Chinese.
  46. Re: Hawkins RG, Houston MC Is population-wide diuretic use directly associated with the incidence of end-stage renal disease in the United States? A hypothesis. Am J Hypertens. 2005 Jun;18(6):744-9
  47. C36AORTIC DISTENSIBILITY IN NORMOTENSIVE, UNTREATED AND TREATED HYPERTENSIVE PATIENTS.
  48. Erratum
  49. P-325: Impact of medical treatment during one month on systolic blood pressure, left ventricular systolic function and natriuretic peptides in patients with heart failure
  50. Clinical experience with perindopril in African-American hypertensive patients: a large United States community trial
  51. Incremental Expenditure of Treating Hypertension in the United States
  52. Antihypertensive Treatment Alters the Predictive Strength of Pulse Pressure and Other Blood Pressure Measures
  53. Association Between Different measurements of Obesity and the Incidence of Hypertension
  54. P-435: Evaluation of hypertension prevalence and blood pressure goal attainment using data from the 1999–2000 national health and nutrition examination survey (nhanes)
  55. P-140: E-prescription database analysis supports use of combination therapy in hypertensive patients with CAD in invest
  56. P-329: Cardiovascular morbid-mortality in hypertensive patients in relation to the presence of left ventricular hypertrophy. 11 years followed-up cohort
  57. D27COMPARATIVE EFFICACY OF HYDROCHLOROTHIAZIDE AND AMLODIPINE IN ELDERLY SUBJECTS WITH AMBULATORY HYPERTENSION.
  58. Exercise Activates Renal Dysfunction in Hypertension
  59. Myocardial Contrast Echocardiography: An Innovative Technique to Assess Myocardial Perfusion in Hypertensive Patients
  60. C18Relationship Between 24H Urinary Albumin Excretion Rate (Uae), Left Ventricular Mass Index (Lvmi) And 24H Ambulatory Blood Pressure (Abp) In Borderline Hypertensives (Bh) And Normotensive Offspring Of Hypertensive Parents.
Search Result: